Proficio Capital Partners LLC Acquires New Position in Humana Inc. (NYSE:HUM)

Proficio Capital Partners LLC acquired a new position in shares of Humana Inc. (NYSE:HUM - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 55,562 shares of the insurance provider's stock, valued at approximately $14,097,000.

Several other hedge funds also recently added to or reduced their stakes in HUM. Janney Montgomery Scott LLC grew its holdings in Humana by 11.6% during the 3rd quarter. Janney Montgomery Scott LLC now owns 3,721 shares of the insurance provider's stock worth $1,179,000 after acquiring an additional 388 shares in the last quarter. Atria Investments Inc grew its holdings in Humana by 18.1% during the 3rd quarter. Atria Investments Inc now owns 5,552 shares of the insurance provider's stock worth $1,759,000 after acquiring an additional 851 shares in the last quarter. Ashton Thomas Securities LLC acquired a new position in Humana during the 3rd quarter worth $31,000. Versor Investments LP grew its holdings in Humana by 90.6% during the 3rd quarter. Versor Investments LP now owns 1,540 shares of the insurance provider's stock worth $488,000 after acquiring an additional 732 shares in the last quarter. Finally, Nations Financial Group Inc. IA ADV grew its holdings in Humana by 5.9% during the 3rd quarter. Nations Financial Group Inc. IA ADV now owns 1,169 shares of the insurance provider's stock worth $370,000 after acquiring an additional 65 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

HUM has been the subject of several recent analyst reports. Piper Sandler raised their price objective on shares of Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a report on Wednesday, January 15th. JPMorgan Chase & Co. decreased their price target on shares of Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $290.00 price target on shares of Humana in a report on Wednesday, February 12th. StockNews.com lowered shares of Humana from a "buy" rating to a "hold" rating in a report on Tuesday. Finally, Barclays lifted their price target on shares of Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a report on Thursday, February 13th. Nineteen equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, Humana currently has a consensus rating of "Hold" and an average price target of $285.68.

Remove Ads

Humana Price Performance

Shares of HUM traded up $5.45 during mid-day trading on Tuesday, hitting $269.86. The company's stock had a trading volume of 1,632,535 shares, compared to its average volume of 1,713,453. The firm has a 50-day moving average price of $271.39 and a 200 day moving average price of $278.89. The stock has a market capitalization of $32.57 billion, a price-to-earnings ratio of 27.12, a PEG ratio of 2.05 and a beta of 0.57. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a fifty-two week low of $213.31 and a fifty-two week high of $406.46.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. On average, research analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a dividend yield of 1.31%. The ex-dividend date is Friday, March 28th. Humana's dividend payout ratio (DPR) is currently 35.58%.

Insider Transactions at Humana

In other news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction that occurred on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company's stock, valued at $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.32% of the stock is currently owned by insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.